Physician

Gautam R Moorjani, MD

According to 2025 Medicare claims, Gautam Moorjani, MD (NPI: 1780617282) practices rheumatology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES OF SOUTH TEXAS, PLLC (NPI: 1952351538; TIN: 161751617) and primary practice location at 78258-3372.

Moorjani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 609 traditional Medicare patients, billed 186,490 HCPCS/CPT codes, and received $2,660,859 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,773 prescription claims across 306 beneficiaries totaling $2,221,437 in drug costs, led by Enbrel Sureclick (Etanercept). 2015 DME data shows 12 claims. Open Payments data shows 112 records totaling $2,550. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,072,506 to $2,660,859. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $706,090 to $2,221,437. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $1,072,506 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,617,668 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,887,067 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,797,762 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,022,444 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,073,809 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,923,536 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,427,630 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,453,696 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,660,859 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201558154,149$1,072,506
201665075,623$1,617,668
201757799,209$1,887,067
201856384,495$1,797,762
2019549109,816$2,022,444
2020497111,246$2,073,809
2021500106,460$1,923,536
2022618164,839$2,427,630
2023616171,349$2,453,696
2024609186,490$2,660,859

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2015 Drug cost: $706,090 (USD; Tot_Drug_Cst)2016 Drug cost: $983,362 (USD; Tot_Drug_Cst)2017 Drug cost: $1,066,163 (USD; Tot_Drug_Cst)2018 Drug cost: $767,804 (USD; Tot_Drug_Cst)2019 Drug cost: $979,356 (USD; Tot_Drug_Cst)2020 Drug cost: $1,125,822 (USD; Tot_Drug_Cst)2021 Drug cost: $1,185,764 (USD; Tot_Drug_Cst)2022 Drug cost: $1,864,390 (USD; Tot_Drug_Cst)2023 Drug cost: $1,839,766 (USD; Tot_Drug_Cst)2024 Drug cost: $2,221,437 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153011,729$706,090
20163332,059$983,362
20173492,256$1,066,163
20183421,833$767,804
20193472,062$979,356
20203411,993$1,125,822
20213091,753$1,185,764
20222931,701$1,864,390
20233101,723$1,839,766
20243061,773$2,221,437

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$152$3052015 Medicare payment: $305 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$305
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more382909$89
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's352689$11
80053Blood test, comprehensive group of blood chemicals346937$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count323852$8
86140Measurement c-reactive protein for detection of infection or inflammation323879$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept1072,996$806,597
Humira(Cf) PenAdalimumab471,316$358,376
Orencia ClickjectAbatacept29812$164,943
RinvoqUpadacitinib22720$154,676
Xeljanz XrTofacitinib Citrate18540$112,079

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.112$2,550Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gautam R. Moorjani, MD?

Tedicare shows public-source Medicare data for Gautam R. Moorjani, MD (NPI 1780617282), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gautam R. Moorjani, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gautam R. Moorjani, MD?

Gautam R. Moorjani, MD is linked to RHEUMATOLOGY ASSOCIATES OF SOUTH TEXAS, PLLC (billing NPI 1952351538) in the available physician profile data.

Does Gautam R. Moorjani, MD have Open Payments data?

Gautam R. Moorjani, MD has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.